cnbc.com / .cnbc-com-health-care / Page 6

Jim Cramer said Friday on CNBC that Abbott stock is "dirt cheap."

Novo Nordisk's drug helped reduce knee pain in osteoarthritis patients with obesity. Meanwhile, the Change Healthcare breach hit at least 100 million Americans.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

The pharmaceutical giant also raised its full-year revenue forecast to an increase of more than 5%.

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.

The CDC believes the risk to the public is "very low" due to the actions taken by McDonald's and Taylor Farms to remove slivered onions from affected locations.

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.

Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.

While revenue slightly missed, an earnings beat along with a number of other positives pushed the stock higher.

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.